SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-051645
Filing Date
2013-09-20
Accepted
2013-09-19 19:04:48
Documents
8
Period of Report
2013-11-07
Effectiveness Date
2013-09-20

Document Format Files

Seq Description Document Type Size
1 v355381_def14a.htm DEF 14A 541463
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_protalix.jpg GRAPHIC 4327
4 GRAPHIC sig_david-aviezer.jpg GRAPHIC 2272
5 GRAPHIC sig_yossi-maimon.jpg GRAPHIC 1357
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC v355381_pc1.jpg GRAPHIC 375916
8 GRAPHIC v355381_pc2.jpg GRAPHIC 174471
  Complete submission text file 0001144204-13-051645.txt   1313162
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 131106418
SIC: 2836 Biological Products, (No Diagnostic Substances)